ArticleIntestinal research2026

Real-world effectiveness and safety of upadacitinib in Korean patients with inflammatory bowel disease: a single-center retrospective study.

Ji Eun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.